Clinics in Dermatology
Volume 25, Issue 1 , Pages 26-32 , January 2007

Abnormal wound healing: keloids

References 

  1. Brissett AE, Sherris DA. Scar contractures, hypertrophic scars, and keloids. Facial Plast Surg. 2001;17:263–272
  2. Lee SS, Yosipovitch G, Chan YH, et al. Pruritus, pain, and small nerve fiber function in keloids: a controlled study. J Am Acad Dermatol. 2004;51:1002–1006
  3. Bayat A, Arscott G, Ollier WE, et al. Description of site-specific morphology of keloid phenotypes in an Afrocaribbean population. Br J Plast Surg. 2004;57:122–133
  4. Burd A, Chan E. Keratinocyte-keloid interaction. Plast Reconstr Surg. 2002;110:197–202
  5. Prado AS, Fontbona M. A 1.8-kg keloid of the arm. Plast Reconstr Surg. 2006;117:335–336
  6. Britto JA, Elliot D. Aggressive keloid scarring of the Caucasian wrist and palm. Br J Plast Surg. 2001;54:461–462
  7. Sandler B. Recurrent plantar keloid. Cutis. 1999;63:325–326
  8. Osswald SS, Elston DM, Vogel PS. Giant right plantar keloid treated with excision and tissue-engineered allograft. J Am Acad Dermatol. 2003;48:131–134
  9. Lindsey WH, Davis PT. Facial keloids. A 15-year experience. Arch Otolaryngol Head Neck Surg. 1997;123:397–400
  10. Gurunluoglu R, Bayramicli M, Numanoglu A. Two patients with penile keloids: a review of the literature. Ann Plast Surg. 1997;39:662–665
  11. Gurunluoglu R, Dogan T, Numanoglu A. A case of giant keloid in the female genitalia. Plast Reconstr Surg. 1999;104:594
  12. Mastrolorenzo A, Rapaccini AL, Tiradritti L, et al. A curious keloid of the penis. Acta Derm Venereol. 2003;83:384–385
  13. Bourcier T, Baudrimont M, Boutboul S, et al. Corneal keloid: clinical, ultrasonographic, and ultrastructural characteristics. J Cataract Refract Surg. 2004;30:921–924
  14. Lee JY, Yang CC, Chao SC, et al. Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol. 2004;26:379–384
  15. Marneros AG, Krieg T. Keloids—clinical diagnosis, pathogenesis, and treatment options. J Dtsch Dermatol Ges. 2004;2:905–913
  16. Messadi DV, Le A, Berg S, et al. Effect of TGF-beta 1 on PDGF receptors expression in human scar fibroblasts. Front Biosci. 1998;3:a16–a22
  17. Sayah DN, Soo C, Shaw WW, et al. Downregulation of apoptosis-related genes in keloid tissues. J Surg Res. 1999;87:209–216
  18. Fujiwara M, Muragaki Y, Ooshima A. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol. 2005;153:295–300
  19. Nakaoka H, Miyauchi S, Miki Y. Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars. Acta Derm Venereol. 1995;75:102–104
  20. Bronson RE, Argenta JG, Bertolami CN. Interleukin-1-induced changes in extracellular glycosaminoglycan composition of cutaneous scar-derived fibroblasts in culture. Coll Relat Res. 1988;8:199–208
  21. Akoz T, Gideroglu K, Akan M. Combination of different techniques for the treatment of earlobe keloids. Aesthetic Plast Surg. 2002;26:184–188
  22. Kelly AP. Medical and surgical therapies for keloids. Dermatol Ther. 2004;17:212–218
  23. Bayat A, Arscott G, Ollier WE, et al. “Aggressive keloid”: a severe variant of familial keloid scarring. J R Soc Med. 2003;96:554–555
  24. Marneros AG, Norris JE, Olsen BR, et al. Clinical genetics of familial keloids. Arch Dermatol. 2001;137:1429–1434
  25. Bayat A, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg. 2003;111:535–543[discussion 544-6]
  26. Bayat A, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease. Exp Dermatol. 2004;13:120–124
  27. Bayat A, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease and transforming growth factor beta 2 polymorphisms. Br J Plast Surg. 2002;55:283–286
  28. Bayat A, Walter JM, Bock O, et al. Genetic susceptibility to keloid disease: mutation screening of the TGFbeta(3) gene. Br J Plast Surg. 2005;58:914–921
  29. Chen W, Fu XB, Ge SL, et al. Development of gene microarray in screening differently expressed genes in keloid and normal-control skin. Chin Med J (Engl). 2004;117:877–881
  30. Berman B, Flores F. The treatment of hypertrophic scars and keloids. Eur J Dermatol. 1998;8:591–595
  31. Sanders KW, Gage-White L, Stucker FJ. Topical mitomycin C in the prevention of keloid scar recurrence. Arch Facial Plast Surg. 2005;7:172–175
  32. Talmi YP, Orenstein A, Wolf M, et al. Use of mitomycin C for treatment of keloid: a preliminary report. Otolaryngol Head Neck Surg. 2005;132:598–601
  33. Mustoe TA, Cooter RD, Gold MH, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560–571
  34. Davison SP, Mess S, Kauffman LC, et al. Ineffective treatment of keloids with interferon alpha-2b. Plast Reconstr Surg. 2006;117:247–252
  35. Kiil J. Keloids treated with topical injections of triamcinolone acetonide (kenalog). Immediate and long-term results. Scand J Plast Reconstr Surg. 1977;11:169–172
  36. Ketchum LD, Robinson DW, Masters FW. Follow-up on treatment of hypertrophic scars and keloids with triamcinolone. Plast Reconstr Surg. 1971;48:256–259
  37. Griffith BH. The treatment of keloids with triamcinolone acetonide. Plast Reconstr Surg. 1966;38:202–208
  38. Griffith BH, Monroe CW, McKinney P. A follow-up study on the treatment of keloids with triamicinolone acetonide. Plast Reconstr Surg. 1970;46:145–150
  39. Berman B, Flores F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol. 1997;37:755–757
  40. Cruz NI, Korchin L. Inhibition of human keloid fibroblast growth by isotretinoin and triamcinolone acetonide in vitro. Ann Plast Surg. 1994;33:401–405
  41. Carroll LA, Hanasono MM, Mikulec AA, et al. Triamcinolone stimulates bFGF production and inhibits TGF-beta1 production by human dermal fibroblasts. Dermatol Surg. 2002;28:704–709
  42. Poochareon VN, Berman B. New therapies for the management of keloids. J Craniofac Surg. 2003;14:654–657
  43. Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J Am Acad Dermatol. 2002;47:S209–S211
  44. Chen MA, Davidson TM. Scar management: prevention and treatment strategies. Curr Opin Otolaryngol Head Neck Surg. 2005;13:242–247
  45. Grimes PE, Hunt SG. Considerations for cosmetic surgery in the black population. Clin Plast Surg. 1993;20:27–34
  46. Har-Shai Y, Amar M, Sabo E. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconstr Surg. 2003;111:1841–1852
  47. Dalkowski A, Fimmel S, Beutler C, et al. Cryotherapy modifies synthetic activity and differentiation of keloidal fibroblasts in vitro. Exp Dermatol. 2003;12:673–681
  48. Lahiri A, Tsiliboti D, Gaze NR. Experience with difficult keloids. Br J Plast Surg. 2001;54:633–635
  49. Luo S, Benathan M, Raffoul W, et al. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg. 2001;107:87–96
  50. Ragoowansi R, Cornes PG, Moss AL, et al. Treatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy. Plast Reconstr Surg. 2003;111:1853–1859
  51. Ogawa R, Mitsuhashi K, Hyakusoku H, et al. Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: retrospective study of 147 cases followed for more than 18 months. Plast Reconstr Surg. 2003;111:547–553[discussion 554-5]
  52. Garg MK, Weiss P, Sharma AK, et al. Adjuvant high dose rate brachytherapy (Ir-192) in the management of keloids which have recurred after surgical excision and external radiation. Radiother Oncol. 2004;73:233–236
  53. Guix B, Henriquez I, Andres A, et al. Treatment of keloids by high-dose-rate brachytherapy: a seven-year study. Int J Radiat Oncol Biol Phys. 2001;50:167–172
  54. Al-Attar A, Mess S, Thomassen JM, et al. Keloid pathogenesis and treatment. Plast Reconstr Surg. 2006;117:286–300
  55. Botwood N, Lewanski C, Lowdell C. The risks of treating keloids with radiotherapy. Br J Radiol. 1999;72:1222–1224
  56. Dinh Q, Veness M, Richards S. Role of adjuvant radiotherapy in recurrent earlobe keloids. Australas J Dermatol. 2004;45:162–166
  57. Hoffman S. Radiotherapy for keloids. Ann Plast Surg. 1982;9:265
  58. Tanzi EL, Alster TS. Laser treatment of scars. Skin Therapy Lett. 2004;9:4–7
  59. Manuskiatti W, Fitzpatrick RE, Goldman MP. Energy density and numbers of treatment affect response of keloidal and hypertrophic sternotomy scars to the 585-nm flashlamp-pumped pulsed-dye laser. J Am Acad Dermatol. 2001;45:557–565
  60. Connell PG, Harland CC. Treatment of keloid scars with pulsed dye laser and intralesional steroid. J Cutan Laser Ther. 2000;2:147–150
  61. Kuo YR, Wu WS, Jeng SF, et al. Activation of ERK and p38 kinase mediated keloid fibroblast apoptosis after flashlamp pulsed-dye laser treatment. Lasers Surg Med. 2005;36:31–37
  62. Kuo YR, Wu WS, Jeng SF, et al. Suppressed TGF-beta1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment. Lasers Surg Med. 2005;36:38–42
  63. Kumar K, Kapoor BS, Rai P, et al. In-situ irradiation of keloid scars with Nd:YAG laser. J Wound Care. 2000;9:213–215
  64. Borgognoni L. Biological effects of silicone gel sheeting. Wound Repair Regen. 2002;10:118–121
  65. de Oliveira GV, Nunes TA, Magna LA, et al. Silicone versus nonsilicone gel dressings: a controlled trial. Dermatol Surg. 2001;27:721–726
  66. Chang CW, Ries WR. Nonoperative techniques for scar management and revision. Facial Plast Surg. 2001;17:283–288
  67. Berman B, Villa A. Imiquimod 5% cream for keloid management. Dermatol Surg. 2003;29:1050–1051
  68. Martin-Garcia RF, Busquets AC. Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study. Dermatol Surg. 2005;31:1394–1398
  69. Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol. 2002;46:S63–S97
  70. Apikian M, Goodman G. Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol. 2004;45:140–143
  71. Uppal RS, Khan U, Kakar S, et al. The effects of a single dose of 5-fluorouracil on keloid scars: a clinical trial of timed wound irrigation after extralesional excision. Plast Reconstr Surg. 2001;108:1218–1224
  72. Nanda S, Reddy BS. Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg. 2004;30:54–56[discussion 56-7]
  73. Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology. 2002;204:130–132
  74. Kontochristopoulos G, Stefanaki C, Panagiotopoulos A, et al. Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study. J Am Acad Dermatol. 2005;52:474–479
  75. Espana A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg. 2001;27:23–27
  76. Saray Y, Gulec AT. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study. Int J Dermatol. 2005;44:777–784
  77. Yosipovitch G, Widijanti Sugeng M, Goon A, et al. A comparison of the combined effect of cryotherapy and corticosteroid injections versus corticosteroids and cryotherapy alone on keloids: a controlled study. J Dermatolog Treat. 2001;12:87–90
  78. Atkinson JA, McKenna KT, Barnett AG, et al. A randomized, controlled trial to determine the efficacy of paper tape in preventing hypertrophic scar formation in surgical incisions that traverse Langer's skin tension lines. Plast Reconstr Surg. 2005;116:1648–1656[discussion 1657-8]

PII: S0738-081X(06)00140-4

doi: 10.1016/j.clindermatol.2006.09.009

Clinics in Dermatology
Volume 25, Issue 1 , Pages 26-32 , January 2007

Article Tools